Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
The latest announcement is out from WuXi AppTec Co., Ltd. Class H ( (HK:2359) ).
WuXi AppTec Co., Ltd. has announced that its board of directors will convene a meeting on March 23, 2026 to review and approve the group’s audited financial results for the year ended December 31, 2025. The board will also consider whether to recommend a final dividend to shareholders and address other corporate matters, signaling an upcoming disclosure of the company’s annual performance and potential cash return to investors.
The announcement outlines the board’s composition, including executive, non-executive and independent non-executive directors, underscoring its governance structure ahead of the key financial review. Investors and other stakeholders will look to the scheduled meeting for clarity on WuXi AppTec’s operational results and capital allocation decisions, which may influence market perceptions of the company’s growth and shareholder-return profile.
The most recent analyst rating on (HK:2359) stock is a Hold with a HK$124.00 price target. To see the full list of analyst forecasts on WuXi AppTec Co., Ltd. Class H stock, see the HK:2359 Stock Forecast page.
More about WuXi AppTec Co., Ltd. Class H
WuXi AppTec Co., Ltd. is a China-incorporated joint stock company listed in Hong Kong that operates through a group structure. The company provides contract research, development and manufacturing services to the pharmaceutical and life sciences industries, supporting global drug discovery and development for a broad base of clients.
Average Trading Volume: 5,173,940
Technical Sentiment Signal: Buy
Current Market Cap: HK$311.8B
For a thorough assessment of 2359 stock, go to TipRanks’ Stock Analysis page.